Relevant bibliographies by topics / ESUS

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'ESUS'

Author: Grafiati
Published: 4 June 2021
Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'ESUS.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "ESUS"

1

Baule, Antonio. "About ESUS…" AboutOpen 4, no. 1 (October 26, 2018): 179–84. http://dx.doi.org/10.19156/abtpn.2018.0070.

Full text
Abstract:
Five subtypes of Ischemic stroke are classified based on therir causes. ESUS (Embolic Stroke of Undetermined Source) stands for a non-lacunar cerebral infarct, in the absence of stenosis of large arteries or causes of cardioembolic stroke. It is estimated that ESUS accounts for about 25% of all ischemic strokes. A multidisciplinary, multistep diagnostic investigation is needed for a correct diagnosis, in order to exclude other possible causes of stroke. At present there are limited indications on how to plan secondary prevention of ischemic stroke in patients with ESUS. In the patient described, cortical ischemia, probably arising following an arterial embolization, represents an index event that could be classified as ESUS: in this case dabigatran was administered off-label, althoughin this type of patient this could be soon supported by the results of the RESPECT-ESUS study, a randomized trial comparing dabigatran and ASA in patients with recent ESUS, to test whether anticoagulant therapy can improve the outcome of patients in this clinical condition (Cardiology).
APA, Harvard, Vancouver, ISO, and other styles
2

Donnan, Geoffrey A. "ESUS and INTERACT." International Journal of Stroke 11, no. 5 (May 26, 2016): 499. http://dx.doi.org/10.1177/1747493016647234.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Leventis, Ioannis, Kalliopi Perlepe, Dimitrios Sagris, Gaia Sirimarco, Davide Strambo, Georgios Georgiopoulos, Ashraf Eskandari, et al. "Characteristics and outcomes of Embolic Stroke of Undetermined Source according to stroke severity." International Journal of Stroke 15, no. 8 (March 2, 2020): 866–71. http://dx.doi.org/10.1177/1747493020909546.

Full text
Abstract:
Background and aims Patients with embolic strokes of undetermined source (ESUS) usually present with mild symptoms. We aimed to compare the baseline characteristics between mild and severe ESUS, identify predictors for severe ESUS, and assess outcomes of patients with severe ESUS. Methods In the AF-ESUS (AF-ESUS) dataset, we stratified ESUS severity using the median National Institutes of Health Stroke Scale (NIHSS) score on admission as cut-off. We performed multivariable stepwise regression analyses to identify independent predictors of severe ESUS and to assess the association between ESUS severity and stroke recurrence, death, and new incident atrial fibrillation (AF) on follow-up. The 10-year cumulative probabilities of outcome incidence were estimated by the Kaplan–Meier product limit method. Results In 772 patients (median NIHSS: 6 (interquartile range: 3–12)), 414 (53.6%) patients had severe ESUS (i.e. NIHSS ≥6). Female sex was the only independent predictor for severe ESUS (odds ratio: 1.72 (1.27–2.33)). The rates of recurrence (3.3%/year vs. 3.4%/year, adjusted-hazard ratio: 1.09 (0.73–1.62)) and new incident AF (13.5% vs. 17.0%, adjusted odds ratio: 0.67 (0.44–1.03)) were similar between severe and mild ESUS, but mortality was higher (5.4%/year vs. 3.7%/year, adjusted-hazard ratio: 1.51 (1.05–2.16)) in severe ESUS. The 10-year cumulative probability for stroke recurrence was similar between severe and mild ESUS (38.1% (29.2–48.6) vs. 36.6% (27.8–47.0), log-rank test: 0.01, p = 0.920). The 10-year cumulative probability of death was higher in patients with severe ESUS compared with mild ESUS (40.5% (32.5–50.0) vs. 34.0% (26.0–43.6) respectively; log-rank test: 4.54, p = 0.033). Conclusions Women have more severe ESUS compared with men. Patients with severe ESUS have similar rates of stroke recurrence and new incident AF, but higher mortality compared with mild ESUS.
APA, Harvard, Vancouver, ISO, and other styles
4

Perera, Kanjana S., Thomas Vanassche, Jackie Bosch, Mohana Giruparajah, Balakumar Swaminathan, Katie R. Mattina, Scott D. Berkowitz, et al. "Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry." International Journal of Stroke 11, no. 5 (April 11, 2016): 526–33. http://dx.doi.org/10.1177/1747493016641967.

Full text
Abstract:
Background Recent evidence supports that most non-lacunar cryptogenic strokes are embolic. Accordingly, these strokes have been designated as embolic strokes of undetermined source (ESUS). Aims We undertook an international survey to characterize the frequency and clinical features of ESUS patients across global regions. Methods Consecutive patients hospitalized for ischemic stroke were retrospectively surveyed from 19 stroke research centers in 19 different countries to collect patients meeting criteria for ESUS. Results Of 2144 patients with recent ischemic stroke, 351 (16%, 95% CI 15% to 18%) met ESUS criteria, similar across global regions (range 16% to 21%), and an additional 308 (14%) patients had incomplete evaluation required for ESUS diagnosis. The mean age of ESUS patients (62 years; SD = 15) was significantly lower than the 1793 non-ESUS ischemic stroke patients (68 years, p ≤ 0.001). Excluding patients with atrial fibrillation ( n = 590, mean age = 75 years), the mean age of the remaining 1203 non-ESUS ischemic stroke patients was 64 years ( p = 0.02 vs. ESUS patients). Among ESUS patients, hypertension, diabetes, and prior stroke were present in 64%, 25%, and 17%, respectively. Median NIHSS score was 4 (interquartile range 2–8). At discharge, 90% of ESUS patients received antiplatelet therapy and 7% received anticoagulation. Conclusions This cross-sectional global sample of patients with recent ischemic stroke shows that one-sixth met criteria for ESUS, with additional ESUS patients likely among those with incomplete diagnostic investigation. ESUS patients were relatively young with mild strokes. Antiplatelet therapy was the standard antithrombotic therapy for secondary stroke prevention in all global regions.
APA, Harvard, Vancouver, ISO, and other styles
5

Hawkes, Maximiliano A., Mauricio F. Farez, Lucia Pertierra, Maia M. Gomez-Schneider, José M. Pastor-Rueda, and Sebastián F. Ameriso. "Differential characteristics, stroke recurrence, and predictors of covert atrial fibrillation of embolic strokes of undetermined source." International Journal of Stroke 13, no. 2 (July 31, 2017): 190–94. http://dx.doi.org/10.1177/1747493017724624.

Full text
Abstract:
Background and purpose Identifying embolic strokes of undetermined source (ESUS) patients likely to harbor atrial fibrillation may have diagnostic and therapeutic implications. Our aim was to examine differences between ESUS and cardioembolic strokes, to evaluate stroke recurrence rate among ESUS and to identify baseline characteristics of ESUS patients who were later diagnosed with atrial fibrillation. Materials and methods We assessed all ischemic stroke patients admitted between June 2012 and November 2013. ESUS were compared to cardioembolic strokes at discharge. After at least 12-month follow-up, ESUS patients diagnosed with atrial fibrillation were compared to those who remained as ESUS. Results There were 236 ischemic strokes, 32.6% were ESUS. Compared to cardioembolic strokes, ESUS were younger (p < 0.0001), had milder strokes (p < 0.05), less prevalence of hypertension (p < 0.05), peripheral vascular disease (p < 0.05), and previous ischemic stroke (p < 0.05). After follow-up, 15% of ESUS patients had stroke recurrences and 12% evidenced paroxysmal atrial fibrillation. ESUS patients diagnosed with atrial fibrillation in the follow-up were older (p < 0.0001), had higher erythrocyte sedimentation rate (p < 0.05), and were more likely to have ≥2 infarcts in the same arterial territory in the initial magnetic resonance imaging (p < 0.05). Conclusions Older age, small-scattered infarcts on initial magnetic resonance imaging and high erythrocyte sedimentation rate levels appear to identify ESUS patients more likely to be diagnosed of atrial fibrillation during follow-up.
APA, Harvard, Vancouver, ISO, and other styles
6

Ziemann, Ulf. "Embolischer Schlaganfall unbekannter Quelle (ESUS)." Der Klinikarzt 48, no. 03 (March 2019): 78–81. http://dx.doi.org/10.1055/a-0861-8564.

Full text
Abstract:
ZUSAMMENFASSUNGESUS (embolischer Schlaganfall unbekannter Quelle) wurde als pathogenetisches Konzept mit der Erwartung entwickelt, dass eine orale Antikoagulation wirksamer als eine Thrombozytenfunktionshemmung einen erneuten Schlaganfall verhindern kann. Zwei pivotale Phase-III-Studien (NAVIGATE ESUS, RE-SPECT ESUS) haben diese Erwartung nicht bestätigt. ESUS ist keine singuläre pathogenetische Entität. Zukünftige Konzepte müssen das berücksichtigen, um einer personalisierten Therapie den Weg zu ebnen.
APA, Harvard, Vancouver, ISO, and other styles
7

Masina, Marco, Annalena Cicognani, Carla Lofiego, Simona Malservisi, Riccardo Parlangeli, and Alessandro Lombardi. "Embolic stroke of undetermined source: a retrospective analysis from an Italian Stroke Unit." Italian Journal of Medicine 10, no. 3 (September 30, 2016): 202. http://dx.doi.org/10.4081/itjm.2016.690.

Full text
Abstract:
The new clinical construct of embolic stroke of undetermined source (ESUS) suggests that many cryptogenic strokes are related to minor-risk covert embolic cardiac sources or to embolus from non-occlusive plaques in the aortic arch or in the cerebral arteries. The authors analyzed the prevalence of ESUS in a real-life condition in Italy and compared the recurrence rates in cryptogenic strokes, cardioembolic strokes, and ESUS. The authors retrospectively reassessed according to ESUS criteria 391 consecutive admissions in a stroke unit where extensive diagnostic search was routinely performed. Recurrences in each stroke type within a 3-year follow-up period (mean time: 25.44 months - standard deviation: 9.42) were also compared. The prevalence of ESUS in the aforementioned cohort was 10.5%. All ESUS patients received antiplatelet agents. Warfarin was prescribed in 56.9% of cardioembolic strokes. The recurrence rate in ESUS patients was 4.4% per year, slightly higher than in cardioembolic strokes (3.5%) and significantly higher than in cryptogenic non-ESUS (1.2%) (P&lt;0.0001). This is the first description of a cohort of ESUS patients in an Italian stroke unit. Patients with ESUS have a significantly higher risk of recurrence than in those with non-ESUS cryptogenic strokes, and slightly higher than in those with cardioembolic strokes. Results support the hypothesis of a more extensive diagnostic evaluation in cryptogenic strokes and the feasibility of such approach.
APA, Harvard, Vancouver, ISO, and other styles
8

Al Khathaami, Ali M., Bayan Al Bdah, Abdulmjeed Alnosair, Abdulkarim Alturki, Rayan Alrebdi, Shorug Alwayili, Sulaiman Alhamzah, Fahad A. M. AlKhathaami, and Nasser Alotaibi. "Characteristics and Outcomes of Younger Adults with Embolic Stroke of Undetermined Source (ESUS): A Retrospective Study." Stroke Research and Treatment 2019 (December 3, 2019): 1–6. http://dx.doi.org/10.1155/2019/4360787.

Full text
Abstract:
Introduction. Embolic stroke of undetermined source (ESUS) in younger adults may have different risk factors compared with ESUS in elderly, and the approach to ESUS in young adults may require new therapies. We aimed to investigate the characteristics and outcomes in younger adults with ESUS at a single centre in Saudi Arabia. Patients and Methods. A retrospective study was conducted using the medical records of younger adults with ESUS according to the criteria of the Cryptogenic Stroke/ESUS International Working Group. Younger adults (aged ≤50 years) with ESUS were compared with older patients, on admission and discharge from hospital, using the modified Rankin scale (mRS) and the National Institute of Health Stroke Scale (NIHSS). Results. Among 147 patients with ESUS, 39 (26.5%) were younger adults. Younger adults compared with older adults with ESUS had fewer vascular risk factors, including lower rates of hypertension (43.6% vs. 70.3%; P=0.004), diabetes (35.9% vs. 57.4%; P=0.03), and dyslipidaemia (12.8% vs. 28.7%; P=0.05). There was no significant difference in poor outcome at discharge (defined as mRS > 2), which was observed in 17.9% of younger adults and 28.7% of older adults. Further, there were no significant differences in stroke severity at discharge (NIHSS score ≤5) or median length of stay. Discussion. Although the outcomes of ESUS do not differ between younger and older patients, younger patients have fewer identified risk factors. Conclusion. This study showed that 26.5% of patients with ESUS were aged ≤50 years. Although younger adults with ESUS had fewer risk factors, there were no significant differences in neurologic disability or mortality at discharge, stroke severity, or median length of stay.
APA, Harvard, Vancouver, ISO, and other styles
9

Navi, Babak B., Scott E. Kasner, Mitchell S. V. Elkind, Mary Cushman, Oh Young Bang, and Lisa M. DeAngelis. "Cancer and Embolic Stroke of Undetermined Source." Stroke 52, no. 3 (March 2021): 1121–30. http://dx.doi.org/10.1161/strokeaha.120.032002.

Full text
Abstract:
One-quarter to one-third of ischemic strokes have no established mechanism after standard diagnostic evaluation and are classified as embolic stroke of undetermined source (ESUS). Failure of randomized trials to demonstrate a benefit of direct oral anticoagulants over aspirin for the treatment of ESUS as a single homogeneous entity has led to renewed interest by stroke experts to divide ESUS into subgroups. Emerging data suggest that active cancer, which is present in 5% to 10% of patients with ESUS, is a distinct and important subgroup of ESUS with unique clinical characteristics, underlying pathophysiologies, and treatment and prognostic considerations. Furthermore, the prevalence of cancer-related ESUS is expected to increase as patients with cancer, even those with distant metastases, survive longer due to improvements in cancer treatments. In this topical review, we examine the epidemiological link between ESUS and cancer, the clinical features and potential mechanistic underpinnings of ESUS with cancer (with a focus on novel biomarkers and their relationship to recurrent stroke and other thromboembolic events), and the potential treatment strategies for cancer-related ESUS. We include a critical appraisal of existing data and ongoing or planned clinical trials of different antithrombotic approaches. As cancer-related ESUS is a dynamic disease with variable course, we recommend close collaboration between neurologists and oncologists to develop individualized management plans.
APA, Harvard, Vancouver, ISO, and other styles
10

Jalini, Shirin, Rajasumi Rajalingam, Rosane Nisenbaum, Angelo Dave Javier, Anna Woo, and Aleksandra Pikula. "Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies." Neurology 92, no. 4 (December 5, 2018): e288-e294. http://dx.doi.org/10.1212/wnl.0000000000006748.

Full text
Abstract:
ObjectiveTo investigate the prevalence and clinical determinants of atrial cardiopathy in patients with embolic stroke of unknown source (ESUS) and compare with other established stroke etiologies.MethodsIn a cross-sectional study of 846 consecutive patients with ischemic stroke, we compared the prevalence of atrial cardiopathy (defined by p-wave terminal force in V1 >5,000 µV·ms or severe left atrial enlargement) between ESUS patients and patients with large artery atherosclerosis (LAA) and small vessel disease (SVD) strokes. Baseline characteristics were also compared between ESUS and cardioembolic (CE) patients.ResultsOf all, 158 (19%) patients met ESUS diagnostic criteria, while others were classified into LAA (n = 224, 26%), SVD (n = 154, 18%), and CE (n = 310, 37%). The prevalence of atrial cardiopathy was higher in ESUS patients compared to noncardioembolic stroke patients (26.6% vs 12.1% in LAA vs 16.9% in SVD; p = 0.001). ESUS patients were younger, were less hypertensive, and had higher cholesterol and low-density lipoprotein levels, but also had less left ventricular or atrial abnormalities when compared to CE patients.ConclusionThe prevalence of atrial cardiopathy was high in ESUS patients compared with patients with nonembolic strokes. Interestingly, ESUS patients were also clinically different from CE patients. While the presence of atrial cardiopathy may reflect a unique mechanism of thromboembolism in ESUS patients, it is still unclear if they may benefit from anticoagulation, or if the presence of atrial cardiopathy in this population could serve as a risk-stratifying marker for stroke recurrence. Further efforts are necessary to provide better characterization of the ESUS population in order to develop better stroke preventive strategies.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "ESUS"

1

Molina, Seguin Jessica. "Caracterización clínica, radiológica, pronóstica y del perfil de biomarcadores de los sujetos con ictus isquémico criptogénico no lacunar de mecanismo embólico." Doctoral thesis, Universitat de Lleida, 2019. http://hdl.handle.net/10803/665836.

Full text
Abstract:
Introducció: L’interés per conèixer les característiques dels pacients amb ictus criptogènic no llacunar de mecanisme embòlic (de l’anglès ESUS) ha crescut últimament desde que es disposa de fàrmacs més segurs pel tractament preventiu. Ens planteguem que els ESUS presenten unes característiques clíniques, radiològiques, perfil de biomarcadors (BM) i pronòstic propis que difereixen de les altres etiologies. Metodologia: Analitzem dues cohorts. La primera cohort prospectiva analitza les característiques clíniques, de neuroimatge, ecocardiogràfiques, BM (NSE, IL-6, hs-CRP, troponina, NT-proBNP, fibrinogen, leucòcits, colesterol tradicional i no-tradicional) i recurrència. La segona cohort determina dades clíniques i de l’evolució intrahospitalaria. Ambdues van analitzar predictors de mal pronòstic en ESUS. Conclusions: Les característiques clíniques, radiològiques i perfil de BM que presenten els ESUS, els diferencien dels altres subtipus inclòs de la FA crònica i de novo. Això implicaria que no tots els ESUS regeixen el seu origen en una font cardioembòlica no detectada, establint diversos subtipus etiològics.
Introducción: El interés por conocer las características de los sujetos con ictus criptogénico no lacunar de mecanismo embólico (del inglés ESUS) ha crecido últimamente tras disponer de fármacos más seguros para el tratamiento preventivo. Nos planteamos que los ESUS presentan características clínicas, radiológicas, perfil de biomarcadores (BM) y pronóstico propios que difieren de las otras etiologías. Metodología: Analizamos dos cohortes. La primera cohorte prospectiva analiza características clínicas, de neuroimagen, ecocardiográficos, BM (NSE, IL-6, hs-CRP, troponina, NT-proBNP, fibrinógeno, leucocitos, colesterol tradicional y no-tradicional) y recurrencia. La segunda cohorte determina datos de la clínica y evolución intrahospitalaria. Ambas analizaron predictores de mal pronóstico en ESUS. Conclusiones: Las características clínicas, radiológicas y perfil de BM que presentan los ESUS, los diferencia de los otros subtipos incluso de la FA crónica y de novo. Esto implicaría que no todos los ESUS rigen su origen en una fuente cardioembólica no detectada, pudiéndose establecer varios subtipos etiológicos.
Introduction: The interest in knowing the characteristics of subjects with embolic source undetermined stroke (ESUS) has increased recently, following the release of safer drugs for preventive treatment. We propose that ESUS subjects exhibit specific clinical and radiological characteristics, biomarker (BK) patterns and a prognosis that differentiates them from other etiologies. Methodology: Two cohorts were analysed. The first prospective cohort analysed clinical, neuroimaging, echocardiography characteristics, BK (NSE, IL-6, hs-CRP, troponin, NT-proBNP, fibrinogen, leukocytes, traditional and non-traditional cholesterol) and recurrence. The second cohort established the clinical and intra-hospital evolution data. In both cohorts, the predictors of poor prognosis in ESUS were analysed. Conclusions: The clinical, radiological and BK profile characteristics of the ESUS differentiates them from the other subtypes, including chronic and the new diagnosis of AF. These results suggest that not all ESUS subjects originate from an undetected cardioembolic source, but in fact could establish several etiological subtypes.
APA, Harvard, Vancouver, ISO, and other styles
2

Bell, K. W. "Baryon production in esup(+)esup(-) annihilation at PETRA." Thesis, University of Oxford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.355729.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Buchholz, Andreas Hohloch Rüdiger Rathgeber Tim. "Vergleich von Open Source ESBs." Stuttgart : Universitätsbibliothek der Universität Stuttgart, 2007. http://nbn-resolving.de/urn:nbn:de:bsz:93-opus-33767.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hawkes, C. M. "A study of the reaction esup(+)esup(-)-musup(+)musup(-)(gamma) at centre of mass energies up to 46.78GeV." Thesis, University of Oxford, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.355754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Dias, Delane Pereira de Oliveira. "Uma ferramenta para a visualização de ESTs." Universidade de São Paulo, 2007. http://www.teses.usp.br/teses/disponiveis/55/55134/tde-08052007-100008/.

Full text
Abstract:
Expressed Sequence Tags (ESTs) são amostras de trechos de genes, que funcionam como moldes na síntese de proteínas. Como a quantidade de ESTs coletados nos últimos anos é muito grande, o uso de computadores tornou-se imprescindível para a identificação de genes, proteínas e para a descoberta de genes homólogos. Este trabalho propõe uma metodologia e implementa uma ferramenta para a visualização de ESTs através de um grafo para auxiliar biólogos na exploração e na descoberta de conhecimento sobre estas seqüências. A metodologia inclui agrupamento usando um programa montador de seqüências e, conseqüentemente, a transformação dos grupos em nós de um grafo. O algoritmo BLAST é usado para procurar alinhamentos entre seqüências, representando-os posteriormente por arestas entre as seqüências mais similares. Para a visualização do grafo utilizamos e modificamos a ferramenta TG WikiBrowser conectada a um banco de dados. O resultado é uma ferramenta interativa baseada em código livre e robusto que funciona em ambientesWindows e Linux. Ela possibilita a fácil exploração do grafo, com diversas funcionalidades como, por exemplo: a expansão e filtragem do grafo, a busca por rótulos ou trechos de seqüências e a visualização detalhada de seqüências e grupos de seqüências. Com isso, os biólogos e especialistas em bioinformática ganham mais uma alternativa de investigação da genética
Expressed Sequence Tags (ESTs) are samples of gene stretches, which play the role of templates in synthesis of proteins. Since the amount of collected ESTs on the past few years is enormous, the use of computers has become essential to fields like gene and protein identification, and gene homology. This work proposes a methodology and a tool for visualization of ESTs as a graph for aiding biologists on exploration and on knowledge discovery about these sequences. The methodology includes clustering of ESTs using an assembly program and, consequently, the transformation of the groups in nodes of a graph. BLAST algorithm is used to search alignments among sequences, later representing them as edges between the most similar sequences. For the graph visualization, we adapted TGWikiBrowser software connected to a database. The result is a robust and open source interactive tool forWindows and Linux. It allows easy graph exploration, with various functionalities, for example: graph expansion and filtering, searching for label or sequence stretches, and detailed visualization of sequences and groups of sequences. Therefore, we hope biologists can count on one more option in genetics research
APA, Harvard, Vancouver, ISO, and other styles
6

Mierzwa, Christof. "Architektur eines ESBs zur Unterstützung von EAI Patterns." [S.l. : s.n.], 2008. http://nbn-resolving.de/urn:nbn:de:bsz:93-opus-35102.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kadlecová, Barbora. "Analýza přeshraniční spolupráce Euroregionu Nisa prostřednictvím EGTC -- ESÚS." Master's thesis, Vysoká škola ekonomická v Praze, 2010. http://www.nusl.cz/ntk/nusl-71964.

Full text
Abstract:
Thesis in its theoretical part deals with cross-border cooperation and analyzes a new legal instrument at EU level - European Grouping of Territorial Cooperation (EGTC). The work describes the instrument, including the establishment of a legal basis. It also deals with the potential use of the EGTC, which focuses on the permanent structure for cross-border cooperation, ie. Euroregions and make a summary of the EGTC already developed within the European Union. The practical part focuses on a description of the Euroregion Neisse, who ordered the creation of a legal entity as one of the main objectives and is currently in the process of preparing the establishment of an EGTC. This section is in addition to the characteristics of the Euroregion analysis of individual steps in the creation, use specific options on the EGTC and the comparison with existing legal entities within the EU. The aim of the thesis is to analyze the EGTC and determine whether it has the potential for the development of the Euroregion Neisse.
APA, Harvard, Vancouver, ISO, and other styles
8

Fryer, Timothy James Osborne. "ESS models of sperm competition." Thesis, University of Sheffield, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.266803.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Calderón, Verástegui Ligia. "Esas acciones que nos sostienen: la naturaleza como "otro"." Canalé, 2012. http://repositorio.pucp.edu.pe/index/handle/123456789/114085.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Marchand, Cécile. "Todas esas muertes de Carlos Droguett : genèse d'un texte." Poitiers, 2000. http://www.theses.fr/2000POIT5022.

Full text
Abstract:
A Valparaiso, en 1905, un émigrant français, Emile Dubois, est exécuté bien qu'il clame son innocence dans la série d'assassinats dont on l'accuse. A partir de ce fait divers, l'écrivain chilien Carlos Droguett écrit un feuilleton "Dubois, artista del crimen", publié dans le journal "Extra" de 1946 à 1947. Vingt-quatre ans plus tard, il obtient le prix Alfaguara pour le roman "Todas esas muertes", qui reprend et développe le feuilleton précédemment cité. C'est précisément à la genèse de ce roman que s'attache cette thèse dont la particularité est de présenter le texte du feuilleton en regard du texte romanesque. Dans un premier temps, le processus de fictionnalisation du fait divers, opéré par l'auteur chilien, nourrit notre propros qui s'attache alors à l'étude des sources utilisées. L'analyse porte ainsi sur la presse contemporaine de l'événement qui a inspiré ces fictions, plus précisément sur le quotidien "El Mercurio de Valparaíso", mais surtout sur une biographie romancée que nos recherches ont mise au jour, "La verdadera historia de Dubois. Las Memorias del célebre criminal", afin de déterminer l'influence de ces sources sur les oeuvres de Carlos Droguett en question. Puis l'étude de la genèse de "Todas esas muertes" se poursuit à travers l'annotation du texte du roman, comparé à celui du feuilleton, par la mise en évidence des différences actantielles, thématiques et linguistiques qui apparaissent entre les deux oeuvres.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "ESUS"

1

Joseph, Smith. Mormony Nom: Esus Khristiĭn bas négén géréé. Utah, Salt Lake: Amerikiĭn négdsén Ulsad khévlév, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gauthier-Pelletier, Laure. Société d'histoire de l'Île Jésus: 25 années d'activités : 1963-1988. Laval: Société d'histoire de l'Île Jésus, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bracharz, Kurt. Esaus Erfüllung. Wien: Falter/Deuticke, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cervera, Alfons. Esas vidas. Barcelona: Montesinos, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sosa, Sindo Pacheco. Esos muchachos. La Habana: Gente Nueva, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bracharz, Kurt. Esaus Erfüllung. Wien: Deuticke, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Esos árboles. San Juan, P.R: Isla Negra Editores, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Atxaga, Bernardo. Esos cielos. Barcelona, España: Ediciones B, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Esas nubes. Buenos Aires: Ediciones Simurg, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Esas vidas. Barcelona: Montesinos, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "ESUS"

1

Ruiz-García, Manuel, Jessica Yanina Arias Vásquez, Armando Castellanos, Lydia Kolter, and Joseph M. Shostell. "Molecular Evolution (Mitochondrial and Nuclear Microsatellites Markers) in the Andean Bear (Tremarctos ornatus; Ursidae, Carnivora): How Many ESUs Are There?" In Conservation Genetics in Mammals, 165–94. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-33334-8_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Charman, Tony, Susan Hepburn, Moira Lewis, Moira Lewis, Amanda Steiner, Sally J. Rogers, Annemarie Elburg, et al. "ESCS." In Encyclopedia of Autism Spectrum Disorders, 1164. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1698-3_100551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Inai, Kei, Alexander K. C. Leung, Jouni Uitto, Gerhard-Paul Diller, Michael A. Gatzoulis, John-John B. Schnog, Victor E. A. Gerdes, et al. "ESS." In Encyclopedia of Molecular Mechanisms of Disease, 617. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-29676-8_6824.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Vogelbach-Woerner, Verena. "Ess-Störungen." In Handbuch der klinisch-psychologischen Behandlung, 281–300. Vienna: Springer Vienna, 2000. http://dx.doi.org/10.1007/978-3-7091-3768-0_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Blum, Andrew F., and R. Thomas Long. "ESS Description." In Fire Hazard Assessment of Lithium Ion Battery Energy Storage Systems, 33–37. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-6556-4_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Albrecht, Miguel A. "ESIS: Science Information Retrieval." In Data Analysis in Astronomy IV, 29–37. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3388-7_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Fajie, and Reinhard Klette. "ESPs in Simple Polygons." In Euclidean Shortest Paths, 171–87. London: Springer London, 2011. http://dx.doi.org/10.1007/978-1-4471-2256-2_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Wolfsberg, Tyra G., and David Landsman. "Expressed Sequence Tags (ESTs)." In Methods of Biochemical Analysis, 283–301. New York, USA: John Wiley & Sons, Inc., 2002. http://dx.doi.org/10.1002/0471223921.ch12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Fiedler, H. "Str ess, oxidativer." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1–3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_2923-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Scheuer, Angelika. "Trainingskurse des ESS." In Human Resources, 143–51. Wiesbaden: Springer Fachmedien Wiesbaden, 2016. http://dx.doi.org/10.1007/978-3-658-12568-4_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "ESUS"

1

Wu, Qing, Maksym Spiryagin, Peter Wolfs, Yan Sun, and Colin Cole. "Simulated Comparison of Energy Storage Systems for Heavy Haul Locomotives." In 2017 Joint Rail Conference. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/jrc2017-2217.

Full text
Abstract:
Diesel locomotives in heavy haul operations are good candidates to adopt energy storage systems (ESSs). This paper modelled a battery ESS and a flywheel ESS for heavy haul locomotives. Three heavy haul trains with different traction plans (diesel, diesel-flywheel, and diesel-battery) were compared. The diesel, flywheel, and battery locomotives have traction powers of 3100 kW, 2000 kW, and 3100 kW respectively. Available energy from the flywheel and battery ESSs are 500 kWh and 5000 kWh respectively. The simulated railway is about 300 km long while the trains are about 10,000 tonnes each. Traction performance and fuel consumption were compared. The results show that, compared with the diesel train, the diesel-flywheel and diesel-battery trains were 13.26% and 9.20% slower in speed respectively. However, they decreased their fuel consumptions by 12.40% and 20.65% respectively.
APA, Harvard, Vancouver, ISO, and other styles
2

Buendia, Patricia, Shu-Ning Hsu, Akira Chiba, John Tyree, and Robert Loredo. "From ESTs to ESRs: Comparative analysis of mutually exclusive exons in 15 species of insects." In 2011 IEEE 1st International Conference on Computational Advances in Bio and Medical Sciences (ICCABS). IEEE, 2011. http://dx.doi.org/10.1109/iccabs.2011.5729938.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kawsar, Ferdaus A., Reza Selim, Syed Hossain, Md Munirul Haque, Mohammad Adibuzzaman, Sheikh Iqbal Ahamed, Md Uddin, et al. "e-ESAS." In the 2nd ACM international workshop. New York, New York, USA: ACM Press, 2012. http://dx.doi.org/10.1145/2248341.2248346.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Krahn, Robert, Bohdan Trach, Anjo Vahldiek-Oberwagner, Thomas Knauth, Pramod Bhatotia, and Christof Fetzer. "P esos." In EuroSys '18: Thirteenth EuroSys Conference 2018. New York, NY, USA: ACM, 2018. http://dx.doi.org/10.1145/3190508.3190518.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

"ESTS 2019 Speakers." In 2019 IEEE Electric Ship Technologies Symposium (ESTS). IEEE, 2019. http://dx.doi.org/10.1109/ests.2019.8847799.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

"ESTS 2019 Sponsors." In 2019 IEEE Electric Ship Technologies Symposium (ESTS). IEEE, 2019. http://dx.doi.org/10.1109/ests.2019.8847817.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"ESAS 2009 Message." In 2009 33rd Annual IEEE International Computer Software and Applications Conference. IEEE, 2009. http://dx.doi.org/10.1109/compsac.2009.225.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"ESTS 2019 Committees." In 2019 IEEE Electric Ship Technologies Symposium (ESTS). IEEE, 2019. http://dx.doi.org/10.1109/ests.2019.8847867.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Konopczynski, M. R., W. R. Moore, and J. J. Hailstone. "ESPs and Intelligent Completions." In SPE Annual Technical Conference and Exhibition. Society of Petroleum Engineers, 2002. http://dx.doi.org/10.2118/77656-ms.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Haque, Md, Ferdaus Kawsar, Mohammad Adibuzzaman, Sheikh Ahamed, Richard Love, Rumana Dowla, David Roe, Syed Hossain, and Reza Selim. "Findings of e-ESAS." In the 2012 ACM annual conference. New York, New York, USA: ACM Press, 2012. http://dx.doi.org/10.1145/2207676.2208532.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "ESUS"

1

Cuenca Navarro, Nicolás. Los fotorreceptores, esas fascinantes células. Sociedad Española de Bioquímica y Biología Molecular (SEBBM), November 2009. http://dx.doi.org/10.18567/sebbmdiv_rpc.2009.11.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sanders, Robert. ESSS Outline: Care experience and employment. Iriss, August 2021. http://dx.doi.org/10.31583/esss.20210803.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Landreth, Ronald. Brominated Sorbents for Small Cold-Side ESPs, Hot-Side ESPs and Fly Ash Use in Concrete. Office of Scientific and Technical Information (OSTI), September 2001. http://dx.doi.org/10.2172/1053787.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sancho, Javier. Las proteínas: esos claros objetos de deseo. Sociedad Española de Bioquímica y Biología Molecular (SEBBM), April 2011. http://dx.doi.org/10.18567/sebbmdiv_anc.2011.04.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Allcock, Annelies. ESSS Outline: Disability, poverty and transitional support. Iriss, January 2019. http://dx.doi.org/10.31583/esss.20190121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sanders, Robert. ESSS Outline: Carers mental and physical health. Iriss, October 2020. http://dx.doi.org/10.31583/esss.20201029.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Conover, David. ICC 2019 ESS code changes. Office of Scientific and Technical Information (OSTI), June 2019. http://dx.doi.org/10.2172/1762667.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Allcock, Annelies. Iriss ESSS Outline: Disability and access to leisure. Iriss, September 2018. http://dx.doi.org/10.31583/esss.20180910.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Allcock, Annelies. Iriss ESSS Outline: Schools, safeguarding and early intervention. Iriss, April 2019. http://dx.doi.org/10.31583/esss.20190429.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sanders, Robert. Iriss ESSS Outline: Digital inclusion, exclusion and partcipation. Iriss, April 2020. http://dx.doi.org/10.31583/esss.20200911.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'ESUS' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography